Tower Research Capital LLC (Trc) Kaleido Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $470 - $15,991	-9,407 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.3 - $2.7 $6,584 - $13,675	5,065 Added 116.65%	9,407 $16,000
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $6,156 - $15,507	2,576 Added 145.87%	4,342 $10,000
Q3 2021 Nov 15, 2021	SELL	$5.36 - $7.99 $12,054 - $17,969	-2,249 Reduced 56.01%	1,766 $10,000
Q2 2021 Aug 16, 2021	SELL	$5.82 - $8.72 $13,368 - $20,029	-2,297 Reduced 36.39%	4,015 $30,000
Q1 2021 May 17, 2021	SELL	$7.2 - $16.82 $27,064 - $63,226	-3,759 Reduced 37.32%	6,312 $51,000
Q4 2020 Feb 16, 2021	SELL	$5.77 - $11.33 $8,989 - $17,652	-1,558 Reduced 13.4%	10,071 $92,000
Q3 2020 Nov 16, 2020	BUY	$5.09 - $11.07 $46,156 - $100,382	9,068 Added 354.08%	11,629 $129,000
Q2 2020 Aug 13, 2020	BUY	$4.62 - $8.01 $11,831 - $20,513	2,561 New	2,561 $19,000
Q1 2020 May 15, 2020	SELL	$3.62 - $9.49 $31,754 - $83,246	-8,772 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$5.02 - $8.87 $44,035 - $77,807	8,772 New	8,772 $44,000
Q3 2019 Nov 05, 2019	SELL	$6.74 - $11.3 $32,493 - $54,477	-4,821 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$11.25 - $18.1 $54,236 - $87,260	4,821 New	4,821 $56,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.